{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:11:10Z","timestamp":1790075470681,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13277-016-5451-x","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T11:32:48Z","timestamp":1476185568000},"page":"16103-16113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47"],"prefix":"10.1007","volume":"37","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"5451_CR1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00405-009-1156-8","volume":"267","author":"TA Papadas","year":"2010","unstructured":"Papadas TA, Alexopoulos EC, Mallis A, Jelastopulu E, Mastronikolis NS, Goumas P. Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2010;267:1095\u2013101.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5451_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00405-010-1403-z","volume":"268","author":"A Mallis","year":"2011","unstructured":"Mallis A, Jelastopulu E, Mastronikolis NS, Naxakis SS, Kourousis C, Papadas TA. Laryngeal cancer and passive smoking: the neglected factor? Eur Arch Otorhinolaryngol. 2011;268:727\u201331.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5451_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"5451_CR4","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1158\/1055-9965.EPI-06-0503","volume":"15","author":"ES Peters","year":"2006","unstructured":"Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT, Glutathione S. Transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15(11):2196\u2013202.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"5451_CR5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1017\/S0022215110001416","volume":"124","author":"S Rota","year":"2010","unstructured":"Rota S, Fidan I, Muderris T, Yesilyurt E, Lale Z. Cytokine levels in patients with Epstein-Barr virus associated laryngeal carcinoma. J Laryngol Otol. 2010;124(9):990\u20134.","journal-title":"J Laryngol Otol"},{"key":"5451_CR6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.oraloncology.2005.02.004","volume":"41","author":"A Altieri","year":"2005","unstructured":"Altieri A, Garavello W, Bosetti C, Gallus S, La Vecchia C. Alcohol consumption and risk of laryngeal cancer. Oral Oncol. 2005;41:956\u201365.","journal-title":"Oral Oncol"},{"key":"5451_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3906\/sag-1305-9","volume":"44","author":"H Simsek","year":"2014","unstructured":"Simsek H, Han U, Onal B, Simisek G. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx. Turk J Med Sci. 2014;44:411\u20136.","journal-title":"Turk J Med Sci"},{"key":"5451_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.crad.2011.08.010","volume":"67","author":"Q Hu","year":"2012","unstructured":"Hu Q, Luo F, Zhu SY, Zhang Z, Mao YP, Hui Guan X. Staging of laryngeal carcinoma: comparison of high-frequency sonography and contrast-enhanced computed tomography. Clin Radiol. 2012;67:140\u20137.","journal-title":"Clin Radiol"},{"key":"5451_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1756-9966-30-73","volume":"30","author":"K Cai","year":"2011","unstructured":"Cai K, Wang Y, Bao X. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. J Exp Clin Cancer Res. 2011;30:73.","journal-title":"J Exp Clin Cancer Res"},{"key":"5451_CR10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.febslet.2012.01.050","volume":"586","author":"K Bian","year":"2012","unstructured":"Bian K, Fan J, Zhang X, Yang XW, Zhu HY, Wang L, Sun JY, Meng YL, Cui PC, Cheng SY, Zhang J, Zhao J, Yang AG, Zhang R. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett. 2012;586:804\u20139.","journal-title":"FEBS Lett"},{"key":"5451_CR11","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.febslet.2011.08.052","volume":"585","author":"F Wang","year":"2011","unstructured":"Wang F, Song G, Liu M, Li X, Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett. 2011;585:3263\u20139.","journal-title":"FEBS Lett"},{"key":"5451_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1389450115666140627104151","volume":"15","author":"H Yu","year":"2014","unstructured":"Yu H, Lu Y, Li Z, Wang Q. microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer. Curr Drug Targets. 2014;15:817\u201328.","journal-title":"Curr Drug Targets"},{"key":"5451_CR13","doi-asserted-by":"crossref","first-page":"e934","DOI":"10.1038\/cddis.2013.462","volume":"4","author":"Y Feng","year":"2013","unstructured":"Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, Zhao SH. A feedback circuit between miR-133 and the ERK1\/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis. 2013;4:e934.","journal-title":"Cell Death Dis"},{"key":"5451_CR14","first-page":"209","volume":"38","author":"N Nohata","year":"2011","unstructured":"Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol. 2011;38:209\u201317.","journal-title":"Int J Oncol"},{"key":"5451_CR15","doi-asserted-by":"crossref","unstructured":"Liu X, Chen Z, Yu J, Xia J, Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009;837514.","DOI":"10.1155\/2009\/837514"},{"key":"5451_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrgastro.2012.210","volume":"10","author":"S Song","year":"2013","unstructured":"Song S, Ajani JA. The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2013;10:109\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5451_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs Jr KD, van Rooijen N, Weissman IL. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009;138:286\u201399.","journal-title":"Cell"},{"key":"5451_CR18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3892\/or.2012.1831","volume":"28","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol Rep. 2012;28:465\u201372.","journal-title":"Oncol Rep"},{"key":"5451_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.","journal-title":"Cell"},{"key":"5451_CR20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3892\/mmr.2014.1929","volume":"9","author":"W Li","year":"2014","unstructured":"Li W, Ma H, Sun J. MicroRNA34a\/c function as tumor suppressors in Hep2 laryngeal carcinoma cells and may reduce GALNT7 expression. Mol Med Rep. 2014;9:1293\u20138.","journal-title":"Mol Med Rep"},{"key":"5451_CR21","first-page":"56","volume":"27","author":"M PN","year":"2014","unstructured":"PN M. World medical association publishes the revised declaration of Helsinki. Natl Med J India. 2014;27:56.","journal-title":"Natl Med J India"},{"key":"5451_CR22","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X","volume":"72","author":"RS Brown","year":"1993","unstructured":"Brown RS, Wahl RL. Overexpression of glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993;72:2979\u201385.","journal-title":"Cancer"},{"key":"5451_CR23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.07.002","volume":"11","author":"M Iborra","year":"2012","unstructured":"Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev. 2012;11:305\u201314.","journal-title":"Autoimmun Rev"},{"key":"5451_CR24","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/1078-0432.CCR-07-0666","volume":"14","author":"TS Wong","year":"2008","unstructured":"Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14:2588\u201392.","journal-title":"Clin Cancer Res"},{"key":"5451_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.urolonc.2010.09.017","volume":"31","author":"Y Uchida","year":"2013","unstructured":"Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N, Nakagawa M. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol. 2013;31:115\u201323.","journal-title":"Urol Oncol"},{"key":"5451_CR26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/bjc.2011.23","volume":"104","author":"H Yoshino","year":"2011","unstructured":"Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer. 2011;104:808\u201318.","journal-title":"Br J Cancer"},{"key":"5451_CR27","first-page":"535","volume":"24","author":"P Wang","year":"2010","unstructured":"Wang P, Fu T, Wang X, Zhu W. Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010;24:535\u20138.","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"5451_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2006.02.013","volume":"13","author":"M Olsson","year":"2006","unstructured":"Olsson M, Nilsson A, Oldenborg PA. Target cell CD47 regulates macrophage activation and erythrophagocytosis. Transfus Clin Biol. 2006;13:39\u201343.","journal-title":"Transfus Clin Biol"},{"key":"5451_CR29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/10409238.2015.1014024","volume":"50","author":"DR Soto-Pantoja","year":"2015","unstructured":"Soto-Pantoja DR, Kaur S, Roberts DD. CD47 signaling pathways controlling cellular differentiation and responses to stress. Crit Rev Biochem Mol Biol. 2015;50:212\u201330.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5451_CR30","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1016\/j.ejca.2013.07.149","volume":"49","author":"H Wang","year":"2013","unstructured":"Wang H. An H, Wang B, Liao Q, Li W, Jin X, cui S, Zhang Y, ding Y, Zhao L: miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer. 2013;49:3924\u201335.","journal-title":"Eur J Cancer"},{"key":"5451_CR31","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PO, Steinberg GK, Li G. So SK, Majeti R, harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL: the CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012;109:6662\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5451_CR32","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/ijc.25284","volume":"127","author":"M Kano","year":"2010","unstructured":"Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127:2804\u201314.","journal-title":"Int J Cancer"},{"issue":"6","key":"5451_CR33","first-page":"1967","volume":"27","author":"J Tao","year":"2012","unstructured":"Tao J, Wu D, Xu B, Qian W, Li P, Lu Q, Yin C, Zhang W. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. Oncol Rep. 2012;27(6):1967\u201375.","journal-title":"Oncol Rep"},{"issue":"5","key":"5451_CR34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6605570","volume":"102","author":"T Chiyomaru","year":"2010","unstructured":"Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010;102(5):883\u201391.","journal-title":"Br J Cancer"},{"issue":"5","key":"5451_CR35","first-page":"1099","volume":"39","author":"N Nohata","year":"2011","unstructured":"Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Identification of novel molecular targets regulated by tumor suppressive miR-1\/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol. 2011;39(5):1099\u2013107.","journal-title":"Int J Oncol"},{"issue":"2","key":"5451_CR36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2012.01.030","volume":"418","author":"T Kinoshita","year":"2012","unstructured":"Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2012;418(2):378\u201383.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5451_CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14728222.2013.733699","volume":"17","author":"DR Soto-Pantoja","year":"2013","unstructured":"Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD. Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47. Expert Opin Ther Targets. 2013;17(1):89\u2013103.","journal-title":"Expert Opin Ther Targets"},{"key":"5451_CR38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138:271\u201385.","journal-title":"Cell"}],"updated-by":[{"DOI":"10.3233\/tub-229002","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"record-id":"40886"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5451-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T09:01:42Z","timestamp":1568451702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5451-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["5451"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5451-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]}}}